Dyne Therapeutics Demonstrates FORCE Platform's Potential to Deliver Potent Exon-Skipping Molecules Directly to Muscle to Treat Duchenne Muscular Dystrophy
Tuesday, May 12, 2020 1 min read
Key Takeaway: Dyne Therapeutics Demonstrates FORCE Platform's Potential to Deliver Potent Exon-Skipping Molecules Directly to Muscle to Treat Duchenne Muscular Dystrophy
Full Press Release Details
Dyne Therapeutics Demonstrates FORCE Platform's Potential to Deliver Potent Exon-Skipping Molecules Directly to Muscle to Treat Duchenne Muscular Dystrophy.